Events in the World RNA Series
mRNA PORTFOLIO
Advance Your mRNA Pipelines to Front-Line Treatments by Successfully Translating Proof-of-Concepts with Safety, Efficacy & Regulatory Approval
Ensuring Critical Regulatory Alignment for Analytical Characterization, Adopting Next-Generation Analytical Methods & Improving mRNA Characterization, Quality & Potency to Safeguard the Commercial Release of Your mRNA Therapeutics & Vaccines
Streamlining Purification, Yield & Scalability of Plasmid & Enzymatic DNA to Harmonize with Regulatory Expectations & Meet Increasing Global Demand for High Quality Therapeutics & Effective Vaccines
Enhance Speed, Purity, Flexibility & Scalability of Your Process Development & Manufacturing to Improve Functionality, Efficacy & Approval Rate of mRNA Drugs Across All Disease Indications
Fast-Track Your mRNA-Based Therapeutics & Vaccines from Discovery to Commercialization by Ensuring Targeted Delivery, Durability & Tolerable Immunogenicity Across All Disease Indications
Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into the Clinic & Beyond
RNA PORTFOLIO
Exposing the Latest Chemical & Pharmaceutical Advancements in RNAi Drug Discovery & Development Through Unlocking Novel Targets, Advancing Extra-Hepatic Delivery & Optimizing Chemical Modifications to Ensure Specific & Efficient Delivery to Target Tissues Across Organs & Diseases
Accelerate Circular, Self Amplifying & Transfer RNA into Safe & Effective Clinical Candidates with Therapeutic Potential Across All Disease by Overcoming Quality, Stability, Delivery & Large Scale Manufacturing Hurdles
Leverage AI, Machine Learning & Computational Modeling to Enhance & Automate Data Generation, Sequence Optimization & Delivery Chemistry for Scalable & Cost Effective RNA Therapeutic Discovery
Enhancing Specificity, Potency & Durability of RNA Editing Medicines by Harnessing Novel Delivery & Screening Platforms to Ensure Robust Clinical Validation in Oncology, CNS & Beyond
Advancing Personalized Cancer Vaccines with Novel Antigen Selectivity, Optimal Combination Strategies & On-Demand Manufacturing Towards Positive Clinical Readouts & First Approvals
Optimizing Lead Discovery, Structural Analysis & Preclinical Modelling to Successfully Develop Stable, Effective & Orally Bioavailable Small Molecule RNA Drugs for Robust Translation into the Clinic